3004.90.92.59 - Other 🖩
Details
| Field | Value |
|---|---|
| Unit of Quantity | kg |
| General Rate of Duty (Column 1 - General) | Free |
| Special Rate of Duty (Column 1 - Special) | N/A |
| Column 2 Rate of Duty | 30% |
| Quota Quantity | N/A |
| Additional Duties | N/A |
Overview
This HTS classification, 3004.90.92.59, encompasses "Other" medicaments that primarily affect the digestive system and do not fall under more specific subheadings. These are pharmaceutical products, presented in measured doses or retail packings, intended for therapeutic or prophylactic use to address conditions related to the digestive tract. This category acts as a residual classification for digestive system medicaments not otherwise specified, such as those for indigestion, bloating, or general digestive discomfort.
It is crucial to distinguish this category from its siblings. For instance, 3004.90.92.50 specifically covers laxatives, while 3004.90.92.55 is for antacids. Furthermore, 3004.90.92.56 and 3004.90.92.57 are designated for medicaments containing specific active ingredients like famotidine or pantoprazole, respectively. Therefore, classification under 3004.90.92.59 requires that the product is not explicitly defined by any of these more granular classifications, despite its primary action on the digestive system.
As this is a leaf node, there are no further subcategories. Classification decisions at this level rely on accurately identifying the primary therapeutic use of the medicament and confirming it does not align with any preceding, more specific HTS provisions for digestive system treatments. This ensures that all medicaments primarily affecting the digestive system, that are not otherwise specified, are correctly accounted for within the HTS framework.